|
04.05.12
|
|
AstraZeneca verkaufen
|
Independent Research GmbH
|
|
04.05.12
|
|
GSK halten
|
Independent Research GmbH
|
|
03.05.12
|
|
HSBC hold
|
Deutsche Bank AG
|
|
03.05.12
|
|
BP outperform
|
RBC Capital Markets
|
|
03.05.12
|
|
Glencore outperform
|
RBC Capital Markets
|
|
03.05.12
|
|
BP buy
|
Banc of America Securities-Merrill Lynch
|
|
03.05.12
|
|
Sky underperform
|
Banc of America Securities-Merrill Lynch
|
|
03.05.12
|
|
Imperial Brands neutral
|
Nomura
|
|
03.05.12
|
|
Sky buy
|
Nomura
|
|
03.05.12
|
|
Standard Chartered neutral
|
Banc of America Securities-Merrill Lynch
|
|
03.05.12
|
|
Shell (ex Royal Dutch Shell) kaufen
|
Hamburger Sparkasse AG (Haspa)
|
|
03.05.12
|
|
HSBC buy
|
Société Générale Group S.A. (SG)
|
|
03.05.12
|
|
3i buy
|
Société Générale Group S.A. (SG)
|
|
03.05.12
|
|
BP outperform
|
RBC Capital Markets
|
|
03.05.12
|
|
BP buy
|
UBS AG
|
|
03.05.12
|
|
Glencore buy
|
UBS AG
|
|
03.05.12
|
|
Vodafone Group outperform
|
Sanford C. Bernstein and Co., Inc.
|
|
03.05.12
|
|
BP outperform
|
Credit Suisse Group
|
|
02.05.12
|
|
BP neutral
|
Nomura
|
|
02.05.12
|
|
Rio Tinto outperform
|
Banc of America Securities-Merrill Lynch
|
|
02.05.12
|
|
Imperial Brands underperform
|
Exane-BNP Paribas SA
|
|
02.05.12
|
|
BP halten
|
Independent Research GmbH
|
|
02.05.12
|
|
Lloyds Banking Group outperform
|
Exane-BNP Paribas SA
|
|
02.05.12
|
|
BP neutral
|
Sarasin Research
|
|
02.05.12
|
|
Imperial Brands buy
|
Société Générale Group S.A. (SG)
|
|
02.05.12
|
|
Lloyds Banking Group buy
|
Société Générale Group S.A. (SG)
|
|
02.05.12
|
|
Rio Tinto outperform
|
Exane-BNP Paribas SA
|
|
02.05.12
|
|
Shell (ex Royal Dutch Shell) buy
|
ING
|
|
02.05.12
|
|
Diageo hold
|
ING
|
|
02.05.12
|
|
Lloyds Banking Group buy
|
Citigroup Corp.
|
|
02.05.12
|
|
BP hold
|
Société Générale Group S.A. (SG)
|
|
02.05.12
|
|
GSK verkaufen
|
Hamburger Sparkasse AG (Haspa)
|
|
02.05.12
|
|
BP neutral
|
Exane-BNP Paribas SA
|
|
30.04.12
|
|
Sky buy
|
Citigroup Corp.
|
|
30.04.12
|
|
Unilever hold
|
ING
|
|
30.04.12
|
|
Currys buy
|
UBS AG
|
|
30.04.12
|
|
Smith Nephew overweight
|
Morgan Stanley
|
|
30.04.12
|
|
Shell (ex Royal Dutch Shell) outperform
|
Exane-BNP Paribas SA
|
|
30.04.12
|
|
Lloyds Banking Group buy
|
Société Générale Group S.A. (SG)
|
|
27.04.12
|
|
Barclays neutral
|
UBS AG
|